XEPA:XETRA:XETRA-Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF EUR Acc (EUR)

ETF | Others |

Last Closing

USD 37.835

Change

-0.31 (-0.80)%

Market Cap

N/A

Volume

1.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.69 (-1.33%)

USD 425.64B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.23 (-1.37%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.36 (-1.34%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.37 (-1.31%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.27 (-1.06%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.67 (-1.45%)

USD 103.65B
8R80:XETRA Amundi Index Solutions - Amund..

-1.26 (-0.88%)

USD 103.65B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.68 (-1.33%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.39 (-0.39%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.32 (-0.23%)

USD 80.38B

ETFs Containing XEPA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.40% 53% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.40% 53% F 57% F
Trailing 12 Months  
Capital Gain 23.48% 58% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.48% 59% D- 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.07% 52% F 52% F
Dividend Return 6.07% 52% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.01% 74% C 79% B-
Risk Adjusted Return 86.60% 86% B+ 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike